社区获得性感染200例应用抗微生物药物分析  

Analysis of Antibacterial Drugs in Treatment of Community Acquired Infection

作　　者：杜晓依[1] 叶 王临润[1] 

机构地区：[1]浙江大学医学院附属第一医院药剂科,杭州310003

出　　处：《医药导报》2004年第11期869-870,共2页Herald of Medicine

摘　　要：目的 :探讨社区获得性感染病例抗微生物药物应用情况。方法 :对 2 0 0 3年 1～ 6月入住浙江大学医学院附属第一医院呼吸内科病房的社区获得性感染患者 2 0 0例应用抗微生物药物进行统计分析。结果 :社区获得性感染患者 2 0 0例中 ,抗微生物药物使用频度从高到低依次为头孢哌酮 /舒巴坦、左氧氟沙星片、左氧氟沙星注射液。涉及 5 5种抗微生物药物。平均每例使用抗微生物药物 (3 .6± 2 .0 )种。在限定日剂量 (DDDs)排序中前 3位抗微生物药物分别为左氧氟沙星片、头孢哌酮 /舒巴坦、左氧氟沙星注射液。每天药费消耗针剂大于片剂。结论 :该院抗微生物药物使用基本合理 ,但亦存在同类药物联合应用等不合理用药现象 ,应进一步加强抗微生物药物的合理应用。Objective:To investigate the usage of antibacterial drugs in 200 community acquired infection patients. Method:Total 200 cases of community acquired infection in ward of respirology from January to June in 2003 were analyzed. Results:About 55 antibacterial drugs were involved in the treatment. The three most frequently used antibacterial drugs were cefoperazone/sulbactam for injection, levofloxacin tablets, levofloxacin injection. The average variety of antibacterial drugs per patient was (3.6±2.0). In addition, the three antibacterial drugs ranked in primacy in DDDs were levofloxacin tablet, cefoperazone/sulbactam for injection, levofloxacin injection. The daily consumption of antibacterial drugs for injection was more than for oral administration. Conclusion:The whole medical quality will be improved by using antibacterial drugs rationally. And there will be less drug-resistance bacteria.

关 键 词：抗微生物药物 感染 社区获得性 用药分析 

分 类 号：R978.1[医药卫生—药品] R969.3[医药卫生—药学]